Ethical considerations for drug clinical trials
10.12026/j.issn.1001-8565.2024.08.03
- VernacularTitle:药物临床试验的责任伦理考量
- Author:
Yue ZHAO
1
;
Jian JIANG
2
;
Hongjiang ZHANG
3
Author Information
1. School of Medical Humanities， Jinzhou Medical University， Jinzhou 121000， China
2. Department of Student Work of the Party Committee， Jinzhou Medical University， Jinzhou 121000， China
3. School of Marxism， Jinzhou Medical University， Jinzhou 121000， China
- Publication Type:Journal Article
- Keywords:
drug clinical trial;
subject;
responsibility ethics;
informed consent
- From:
Chinese Medical Ethics
2024;37(8):890-895
- CountryChina
- Language:Chinese
-
Abstract:
In the process of drug clinical trials， while proposing positive countermeasures to the legal and practical issues they raise， more attention should be paid to the ethical aspects of their responsibility， such as loss of the subjects’ sense of personal responsibility， insufficient supervision by regulatory bodies， responsible parties of researcher ignoring the spirit of the contract， and conflicts between professional requirements and individual requirements. In response to the above issues， based on the principle of responsible ethics， specific countermeasures were proposed， such as cultivating personal awareness of responsibility ethics， strengthening the standards of industry ethical review， improving informed consent compensation clauses， and cultivating research subjects’ awareness of responsibility ethics， thus to enhance the protection of the rights and interests of drug clinical trials’ subjects， as well as to protect the subjects’ rights and interests of life and health.
